GENEVA

Think about the last time you had a really severe chest infection.

 

CLAY

Oh yeah.

 

GENEVA

You know, you went to the doctor, they wrote you a prescription, and you took a pill.

 

CLAY

Right, that's standard.

 

GENEVA

Yeah, you swallow this little capsule with a glass of water, and you're just sort of hoping that the medicine will survive the highly corrosive acid in your stomach. And then, you know, get absorbed through your intestinal walls, into your bloodstream, travel all the way through your circulatory system, and eventually, hopefully find its way into the delicate tissues of your lungs.

 

CLAY

It is a profoundly circuitous route.

 

GENEVA

Yeah.

 

CLAY

Like, we just accept systemic delivery as the default reality of modern medicine.

 

GENEVA

Yeah, we do.

 

CLAY

We're totally willing to flood the entire human body with a pharmaceutical compound just to treat a, you know, a highly localized problem in the respiratory tract.

 

GENEVA

Right. I mean, taking a systemic pill for a localized lung infection is essentially like watering your entire garden just to reach one single thirsty plant. Exactly.

 

It is incredibly inefficient. And yet, for most of medical history, that was kind of the only safe option we had.

 

CLAY

Yeah, because the lungs have always been considered far too fragile to be exposed directly to antiseptics. Right.

 

GENEVA

But today, we are unpacking a radical paradigm shift in respiratory medicine. We're pulling from Chapter 6 of the Essential Guide to HOCL, and our mission for this deep dive is to explore this transition from, you know, swallowing systemic pills to directly breathing targeted medicine.

 

CLAY

Yes.

 

GENEVA

And we are looking at a very specific molecule called hypochlorous acid, or HOCL.

 

CLAY

And to really grasp why inhaling HOCL is such a massive departure from traditional pharmacology, we first have to look at the baseline biology of what is actually already happening inside your lungs right now.

 

GENEVA

Okay.

 

CLAY

Because the human body doesn't just wait passively for a pill to arrive via the bloodstream.

 

GENEVA

Right.

 

CLAY

You have a built-in, highly targeted defense system in your airways, and it relies entirely on HOCL.

 

GENEVA

Okay, let's unpack this, because I think most people assume HOCL is just some external chemical that we synthesized in a lab somewhere.

 

CLAY

Right, like a new drug.

 

GENEVA

Yeah, but it's actually native to our biology.

 

CLAY

Entirely native. I mean, when a pathogen enters your airways, your immune system deploys these patrol cells, neutrophils, and macrophages.

 

GENEVA

Okay.

 

CLAY

And they hunt down the invading bacteria or the virus, they engulf it, and then they trigger this process that's known as a respiratory burst.

 

GENEVA

A respiratory burst.

 

CLAY

Yeah. Inside the cell, they rapidly manufacture and release micromolar bursts of HOCL directly onto the pathogen.

 

GENEVA

Let's pause on that phrase, micromolar burst, because it sounds intense, but we are talking about a microscopic scale here.

 

CLAY

Yes, very small.

 

GENEVA

What does that actually mean in terms of cellular chemistry?

 

CLAY

So a micromole is a tiny concentration. It's one millionth of a mole per liter. If you had a micromolar concentration of something in a normal glass of water, you wouldn't even notice it.

 

GENEVA

Right.

 

CLAY

But inside the microscopic sealed chamber where a neutrophil has trapped a bacteria, releasing a micromolar burst of HOCL is essentially unleashing a localized chemical flood. Oh, wow. It is a highly precise strike.

 

The HOCL violently tears electrons away from the pathogens, structural proteins, and its RNA, and it just neutralizes the threat instantly.

 

GENEVA

Which makes total sense biologically. I mean, the body is spot treating the infection right at the source.

 

CLAY

Exactly.

 

GENEVA

But here is where I kind of get stuck. If our neutrophils are already manufacturing this exact molecule in the lungs to fight infections, why do we still get severe pneumonias?

 

CLAY

That's the big question.

 

GENEVA

Right. And why hasn't medicine just supplemented the lungs with extra HOCL like decades ago?

 

CLAY

To answer the first part, we get sick because pathogens replicate exponentially.

 

GENEVA

Okay.

 

CLAY

Sometimes a viral load simply outpaces the number of neutrophils available to fight it. Or, you know, the pathogen deploys evasion tactics.

 

GENEVA

So we just get overwhelmed.

 

CLAY

Right. Now, to answer the second part, why haven't we supplemented it before? That comes down to the brutal laws of chemical stability and physical delivery.

 

For a very long time, we just couldn't manufacture pure HOCL outside the body that wouldn't degrade almost immediately.

 

GENEVA

And would just fall apart. Exactly.

 

CLAY

And even if we could keep it stable, we didn't have the fluid dynamics sorted out to deliver it safely into the deepest, you know, the deepest architecture of the lungs.

 

GENEVA

Because you obviously can't just pour a liquid solution down a patient's windpipe.

 

CLAY

No.

 

GENEVA

You'd drown them.

 

CLAY

Right. Exactly. You'd drown them.

 

So you have to turn it into a breathable gas or a suspended aerosol. And that requires highly calibrated nebulization. You are essentially forcing the liquid HOCL through a vibrating mesh.

 

Or you're using compressed air to shear it into this unimaginably fine mist. Right. But you can't just make a mist of any random size.

 

The droplets have to be engineered to a highly specific diameter.

 

GENEVA

And it's precisely one to five microns, right?

 

CLAY

Precisely one to five microns, yes.

 

GENEVA

And the physics of that one to five micron window is absolutely fascinating to me, because it's not just some arbitrary number.

 

CLAY

No, not at all.

 

GENEVA

Just to put a micron in perspective for everyone, a single human hair is about 70 microns thick. So we are talking about droplets that are incredibly small.

 

CLAY

Yeah.

 

GENEVA

Why does it have to be that exact size? Like, what happens if a nebulizer produces a 10 micron droplet?

 

CLAY

Okay. So if the droplet is 10 microns or larger, it carries too much mass and too much momentum.

 

GENEVA

Okay.

 

CLAY

When you inhale, the air rushes in and makes a sharp turn down your trachea.

 

GENEVA

Right.

 

CLAY

A 10 micron droplet has too much inertia. It literally can't make the turn.

 

GENEVA

Oh.

 

CLAY

So it just crashes into the back of your throat, or gets stuck in the mucus of your upper airways. It never actually reaches the lungs.

 

GENEVA

It's called inertial impaction, right?

 

CLAY

Yes.

 

GENEVA

The heavy droplets just smash into the walls of the upper airway guards?

 

CLAY

Precisely. Now, on the flip side of that, if the droplet is too small, say it's like 0.1 microns, it's so light that it just floats in the airstream.

 

GENEVA

Oh, I see.

 

CLAY

You inhale it, it never settles on the lung tissue, and you simply exhale it right back out.

 

GENEVA

So it just goes in and out without doing anything.

 

CLAY

Right. But that one to five micron range is the aerodynamic sweet spot. The sweet spot.

 

Droplets of that specific size bypass the throat. They navigate the branching bronchi, and they drift perfectly down into the alveoli, where they finally settle onto the tissue through what's called Brownian motion.

 

GENEVA

Wow. So by engineering the mist to that exact aerodynamic specification, you are effectively painting the walls of the alveoli with the exact same antimicrobial molecule your immune cells are struggling to produce.

 

CLAY

Yes.

 

GENEVA

You are literally airdropping reinforcements directly onto the battlefield.

 

CLAY

That is exactly what you were doing.

 

GENEVA

Okay. I have to jump in here and play the role of the skeptical listener for a second.

 

CLAY

Please do.

 

GENEVA

Let's look at the actual chemistry here. The formula is HOCL, hydrogen, oxygen, chlorine. It has chlorine in it.

 

And chlorine gas is highly toxic. I mean, it was literally used as a chemical weapon in World War I. Yes, it was.

 

So why isn't breathing an aerosolized mist of a chlorine-based chemical incredibly dangerous to the super fragile tissue in the alveoli?

 

CLAY

It's a very critical question, and it all hinges on the delicate chemistry of pH levels. You're totally right that chlorine can be highly toxic, but pure aqueous HOCL is a completely different chemical species. And its safety relies entirely on a very, very narrow pH window.

 

GENEVA

How narrow are we talking?

 

CLAY

Very narrow. So if you take chlorine and water and drop the pH down to an acidic level, so anything below pH of three, the equilibrium shifts, and you generate toxic chlorine gas.

 

GENEVA

Okay. So that's the bad stuff.

 

CLAY

Right. You definitely do not want to inhale that.

 

GENEVA

Got it.

 

CLAY

Now, if you swing to the opposite end of the spectrum and push the pH up to an alkaline level, say 12 or 13, the molecule shifts into hypochlorite, and that is standard household bleach.

 

GENEVA

And bleach is incredibly harsh. I mean, it destroys human tissue on contact.

 

CLAY

Right, because bleach is a negatively charged ion. It is corrosive, and it's entirely incompatible with delicate lung tissue.

 

GENEVA

Right.

 

CLAY

But if you hold the chemistry right in the middle, in this mildly acidic sort of green zone, between a pH of 3.8 and 5.5, the molecule stabilizes as pure hypochlorous acid.

 

GENEVA

So it's the exact same constituent atoms, just structurally arranged differently depending on the acidity of the surrounding water.

 

CLAY

Yes. And in that specific 3.8 to 5.5 pH range, HOCL is completely uncharged.

 

GENEVA

Oh.

 

CLAY

It is electrically neutral. And that neutral charge is the absolute secret to its biocompatibility.

 

GENEVA

Because it doesn't have a charge, it doesn't react violently.

 

CLAY

Exactly. Because it lacks a charge, human cells don't perceive it as an abrasive threat. It has the exact same electrical and chemical profile as the molecule your neutrophils produce.

 

GENEVA

Wow.

 

CLAY

So when it is manufactured purely in that window, clinical studies confirm it does not irritate lung tissue, it doesn't sting, it doesn't cause inflammation, and it is safe for repeated inhalation.

 

GENEVA

That is a massive biochemical distinction. And it really underscores why this couldn't be done 50 years ago. We just didn't have the precision manufacturing to hold that chemical equilibrium perfectly stable.

 

CLAY

We didn't.

 

GENEVA

So we have the delivery physics figured out and the biocompatibility validated. Let's talk about what happens when you actually deploy this in a real-world medical crisis.

 

CLAY

Yeah. The clinical data from the COVID-19 pandemic provides one of the clearest windows into how powerful this really is.

 

GENEVA

Okay.

 

CLAY

Picture a hospital ward during the height of the crisis. You have patients with severe viral pneumonia who were deteriorating rapidly. Traditional systemic antibiotics are completely useless because the pathogen is viral, not bacterial.

 

GENEVA

Right.

 

CLAY

And simply increasing their oxygen supply isn't stopping the underlying damage that's occurring in the alveoli.

 

GENEVA

So the medical staff is essentially just watching the lungs lose the battle in real time.

 

CLAY

Yes.

 

GENEVA

But in the trials detailed in the text, when these patients were given a fine mess of pure HOCL to inhale, the trajectory shifted dramatically.

 

CLAY

It really did.

 

GENEVA

And it wasn't just because the HOCL was killing the virus. There is a multi-layered mechanism at play here.

 

CLAY

Yeah. HOCL operates on three distinct fronts simultaneously.

 

GENEVA

Okay. What's the first?

 

CLAY

The first is direct antimicrobial action. As we discussed, the neutral HOCL molecule easily penetrates the viral envelope.

 

GENEVA

Okay.

 

CLAY

It oxidizes the surface proteins and tears apart the viral RNA, literally physically inactivating the virus.

 

GENEVA

Wow.

 

CLAY

And crucially, it also sweeps the area of secondary bacteria.

 

GENEVA

Which is vital because in a lot of viral pneumonias, it's actually a secondary bacterial infection that ultimately kills the patient. So it clears the microbial invaders. But the virus itself is only half the problem in COVID, right?

 

CLAY

You're right.

 

GENEVA

The real danger is the immune system's reaction, the infamous cytokine storm.

 

CLAY

Yes.

 

GENEVA

If the immune system is panicking and just flooding the lungs with inflammation, why don't these patients still drown in their own fluid even if the virus is dead?

 

CLAY

That brings us to the second mechanism, which is its anti-inflammatory properties.

 

GENEVA

Okay.

 

CLAY

A cytokine storm happens when the immune system gets locked in this positive feedback loop.

 

GENEVA

Right.

 

CLAY

It's releasing a flood of signaling proteins called cytokines that basically tell the body to keep sending fluid and destructive cells to the lungs.

 

GENEVA

Just nonstop panning.

 

CLAY

Right. But HOCL actually intercepts those signals.

 

GENEVA

Wait, how does it do that mechanically? Does it just like destroy the immune cells?

 

CLAY

No, it alters the communication network itself. HOCL specifically targets and oxidizes the sulfur-containing amino acids on the cytokine proteins.

 

GENEVA

Okay.

 

CLAY

By oxidizing them, it subtly changes their physical shape.

 

GENEVA

Ah.

 

CLAY

Because biological receptors operate on a lock and key mechanism, once the cytokine shape has changed, it can no longer bind to the immune receptors.

 

GENEVA

Oh, so the key literally doesn't fit the lock anymore.

 

CLAY

Exactly. The key doesn't fit. The panic signal is effectively muted.

 

GENEVA

Wow.

 

CLAY

The HOCL calms the cytokine storm down without globally shutting down the entire immune system.

 

GENEVA

That is incredible. I mean, it kills the virus and then chemically edits the distress signals to stop the body from destroying its own tissue.

 

CLAY

It's remarkably elegant.

 

GENEVA

And what about the physical symptoms, like the severe shortness of breath?

 

CLAY

At the third front, mucus thinning.

 

GENEVA

Okay.

 

CLAY

In severe respiratory distress, the lungs produce excessive, highly viscous mucus. Right.

 

GENEVA

And this mucus is held together by tightly cross-linked mucin polymers. Those polymers are bound by really strong disulfide bonds. Okay.

 

CLAY

So it's thick and sticky.

 

GENEVA

Very sticky. When the HOCL mist drifts down into the bronchi, it chemically cleaves those disulfide bonds. It just cuts them.

 

Exactly. The dense polymer network literally unzips. The mucus becomes thinner, it becomes more liquid, and the patient can easily cough it up and actually clear their airways.

 

CLAY

So you have viral eradication, inflammation dampening, and physical mucus clearance, all happening simultaneously just from inhaling this precise mist.

 

GENEVA

Yes.

 

CLAY

It's an absolute reimagining of critical care.

 

GENEVA

It really is.

 

CLAY

But this isn't exclusively for acute crises in a pandemic ward. The text outlines a really powerful case study regarding chronic pediatric conditions, specifically a 10-year-old boy named Daniel.

 

GENEVA

Yeah. Daniel's case perfectly illustrates the fundamental difference between inhaling HOCL and swallowing traditional pharmaceuticals. So Daniel has a history of asthma, and he develops a severe compounding case of bronchitis.

 

And any parent listening knows the total panic of this scenario.

 

CLAY

Oh, absolutely.

 

GENEVA

His standard steroid inhalers aren't providing relief, and oral antibiotics are doing nothing because the bronchitis is viral. Right. He's wheezing heavily, and his blood oxygen saturation is just steadily dropping.

 

CLAY

In the standard paradigm of respiratory medicine, the next step would simply be to escalate the steroids.

 

GENEVA

Give him a higher dose.

 

CLAY

You'd give him a stronger dose, maybe an oral corticosteroid pill. But steroids are a blunt instrument. They work by systemically suppressing immune transcription.

 

They basically turn off the body's natural inflammatory defenses to force the airways to open.

 

GENEVA

But shutting down the immune system while a child has an active viral infection seems totally counterproductive.

 

CLAY

It is a terrible catch-22. Yeah. But when Daniel's doctor pivoted to inhaled HOCL therapy, instead of escalating the steroids, they bypassed that catch-22 entirely.

 

Wow. Daniel inhaled the 1-5 micron mist. And within a short period, his thickened mucus cleared, his wheezing subsided, and his oxygen levels completely stabilized.

 

GENEVA

So I want to push on this a little bit. Is HOCL acting as an anti-asthma drug? Like, does it cure asthma?

 

CLAY

No, it doesn't cure asthma. Asthma is a hyperreactive immune response to a trigger. Right.

 

What the HOCL does is systematically clear out the trigger.

 

GENEVA

Ah, I see.

 

CLAY

By directly neutralizing the viral and bacterial load in Daniel S. Bronke, the HOCL took the massive microbial burden off his immune system. Right.

 

Once the invading pathogens were oxidized and cleared, his immune system just no longer had a reason to mount such a massive inflammatory asthma response.

 

GENEVA

So instead of a steroid, which just suppresses the immune system to mask the symptom, the HOCL actively supports the immune system by eliminating the root cause.

 

CLAY

Exactly.

 

GENEVA

It allows the body to stand down naturally.

 

CLAY

Right. It's a localized rescue mission.

 

GENEVA

But this makes me wonder, if this works so effectively locally in one boy's lungs to clear an active infection, is there a way to scale this up?

 

CLAY

What do you mean?

 

GENEVA

Like, could we use this mist not just to rescue the sick, but to protect an entire room of vulnerable people before they get infected?

 

CLAY

Oh, that question represents the ultimate leap in this paradigm shift.

 

GENEVA

Yeah.

 

CLAY

We are moving from personal, localized medicine to scalable environmental defense.

 

GENEVA

Let's talk about the elderly care facility that was discussed in the research. We have this enclosed environment where every single winter, despite rigorous vaccination campaigns, seasonal influenza outbreaks just sweep through the halls.

 

CLAY

Right.

 

GENEVA

It is incredibly dangerous for the residents. And historically, the only protocol is to wait for the first person to get sick and then frantically try to isolate them.

 

CLAY

Yeah. The traditional preventative model is highly reactive.

 

GENEVA

Very.

 

CLAY

But in this intervention, the facility shifted to a proactive environmental model.

 

GENEVA

Okay.

 

CLAY

They installed specialized HOCL humidifiers in the common areas, the dining halls and the living rooms.

 

GENEVA

Wow.

 

CLAY

And these devices released a continuous ultra low-level aerosol of HOCL directly into the ambient air.

 

GENEVA

And what were the clinical outcomes for the residents sitting in that mist? I mean, did it work?

 

CLAY

It worked incredibly well. The facility recorded a dramatic, statistically massive drop in seasonal influenza infections.

 

GENEVA

That's amazing.

 

CLAY

And equally important, there were zero reports of respiratory irritation from the residents.

 

GENEVA

So they didn't even notice it.

 

CLAY

No. They were simply breathing the ambient air, watching television, and the outcome was a sharp decrease in hospital transfers for severe pneumonia.

 

GENEVA

It completely flips the script on how we handle sanitation. I mean, we've spent decades obsessing over wiping down countertops with bleach, but respiratory viruses don't really spread on countertops.

 

CLAY

No, they don't.

 

GENEVA

They spread via aerosolized droplets in the air.

 

CLAY

Exactly. Misting HOCL into the environment treats the air itself as a vector.

 

GENEVA

Right.

 

CLAY

The neutral HOCL molecules are colliding with the aerosolized flu viruses in midair, oxidizing their RNA and neutralizing the threat long before those viruses ever have a chance to reach a resident's alveoli.

 

GENEVA

That is wild.

 

CLAY

You are effectively sanitizing the air they breathe in real time.

 

GENEVA

Which brings us to the hardest, most intense indoor environment imaginable, the intensive care unit. I really want to look closely at the data on ventilators. We know mechanical ventilators are life-saving devices, but they introduce an extraordinarily high risk of VAP, or ventilator-associated pneumonia.

 

CLAY

VAP is notoriously one of the deadliest hospital-acquired infections globally.

 

GENEVA

Yeah.

 

CLAY

And the mechanics of it are pretty grim. When a patient is intubated, a plastic endotracheal tube is placed directly into their sterile lower airways. Right.

 

Almost immediately, opportunistic bacteria like pseudomonas begin to colonize the surface of that foreign plastic tube.

 

GENEVA

And they don't just sit there, they actively build a biofilm, which is essentially an extracellular polymeric substance. Basically a dense, slimy matrix they secrete to protect themselves.

 

CLAY

Yeah, that matrix is the core of the problem. Why? If you try to treat that colonization by pumping the patient's bloodstream full of heavy-hitting systemic IV antibiotics, it often just fails.

 

GENEVA

Why does it fail, though? Are the antibiotics just physically blocked by the slime?

 

CLAY

It's largely an issue of molecular size and electrical charge. Think of that biofilm matrix like a microscopic chain-link fence, right?

 

GENEVA

OK, a fence.

 

CLAY

Traditional antibiotics, like vancomycin, are massive, bulky molecules, and they often carry an electrical charge.

 

GENEVA

Right.

 

CLAY

So when they try to penetrate the biofilm, they either get physically tangled in the structural gaps of the fence, or they're electrically repelled by the charge of the matrix itself.

 

GENEVA

Wow, they can't even get in.

 

CLAY

No, they can't reach the bacteria hiding deep inside.

 

GENEVA

But if you bypass the bloodstream and nebulize pure HOCL directly through the ventilator circuit...

 

CLAY

The dynamics change entirely.

 

GENEVA

Because it's different mechanically.

 

CLAY

Right. Remember, HOCL is a remarkably small molecule, and crucially, it is completely uncharged. It's neutral.

 

Because it is electrically neutral and physically tiny, it doesn't get repelled or tangled. It slips effortlessly through the gaps in the biofilm's chain-link fence. Like a ghost.

 

Basically.

 

GENEVA

Yeah.

 

CLAY

Once inside, it oxidizes the proteins holding the matrix together, dismantling the biofilm from the inside out, and eradicating the bacteria.

 

GENEVA

By nebulizing HOCL continuously, you are keeping the airway surfaces and the plastic tubing completely disinfected. Yes. You are breaking down the structural integrity of the biofilm before it can ever fully establish itself.

 

CLAY

Exactly.

 

GENEVA

And by preventing that bacterial colonization locally, you drastically reduce the need to pump that ICU patient full of systemic IV antibiotics.

 

CLAY

Which is absolutely critical for the future of medicine.

 

GENEVA

Yeah.

 

CLAY

Because in modern ICUs, we are increasingly fighting superbugs that are fully resistant to those systemic antibiotics anyway. We are solving what is essentially a mechanical problem, a colonized plastic tube with a localized biocompatible chemical flush...

 

GENEVA

Yeah.

 

CLAY

...rather than relying on failing systemic drugs.

 

GENEVA

What does this all mean? If we synthesize the big picture from everything we've explored in this deep dive today, we are looking at a molecule that possesses a really profound dual role.

 

CLAY

It does.

 

GENEVA

On the micro level, it is a highly targeted localized medicine for the individual. Like Daniel inhaling a three micron mist to clear the viral load in his bronchi and halt an asthma attack. And on the macro level, it serves as a preventative environmental shield for the community.

 

Like the ambient humidifiers neutralizing influenza in the air of a nursing home.

 

CLAY

That dual utility is virtually unheard of in standard pharmacology.

 

GENEVA

Yeah.

 

CLAY

I mean, you cannot vaporize liquid amoxicillin into the HVAC system of a nursing home.

 

GENEVA

No, definitely not.

 

CLAY

And you cannot inhale aerosolized Lysol to cure your bronchitis. No. Pure HOCL successfully bridges the historical gap between environmental sanitation and internal medical therapy.

 

Strictly because it is the exact same molecule our own evolutionary biology selected for both defense and healing.

 

GENEVA

It has been such a wild journey through the respiratory system today. We started at the cellular level, looking at how a neutrophil deploys a micromolar burst of HOCL to tear electrons off a pathogen. We unpacked the strict physics of nebulization, exploring why a droplet must be precisely one to five microns to bypass inertial impaction and just ride Brownian motion into the alveoli.

 

CLAY

We explored the delicate pH equilibrium that separates highly toxic chlorine gas from perfectly safe, uncharged HOCL. We saw how its ability to oxidize signaling proteins dampens the lethal cytokine storms of COVID-19 and how it cleaves disulfide bonds to liquefy suffocating mucus.

 

GENEVA

And we zoomed out to see how its unique lack of electrical charge allows it to slip through the dense molecular fencing of an ICU biofilm, offering a critical alternative to failing systemic antibiotics.

 

CLAY

Which perfectly encapsulates why this paradigm shift is happening right now. We're entering a highly precarious era of medicine.

 

GENEVA

We really are.

 

CLAY

Antibiotic resistance is rising exponentially. The systemic pills we have relied on for nearly a century are beginning to fail us. And simultaneously, we are facing the continuous, unpredictable threat of novel airborne respiratory viruses.

 

GENEVA

We literally cannot afford to keep crossing our fingers, swallowing a pill into our stomachs and just hoping it magically saves our lungs.

 

CLAY

Exactly. Shifting our collective medical mindset from swallowing systemic pills to breathing targeted. Natural medicine is not just an interesting alternative therapy.

 

It could fundamentally be one of the most vital public health defenses we develop in our lifetime. We are finally learning to mimic the innate chemical wisdom of the human body on a macro scale.

 

GENEVA

It absolutely forces you to rethink how we interact with the spaces around us and what the future of public infrastructure might actually look like. Which brings me to a final thought I want to leave you all with.

 

CLAY

Okay.

 

GENEVA

If we now possess the technology to safely mist the exact immune molecules our bodies manufacture into the air of a nursing home to eradicate the winter flu, imagine what would happen if we integrated this precise biocompatible mist directly into the commercial HVAC systems of our airplanes, our public schools, and our crowded subways?

 

CLAY

Wow.

 

GENEVA

Could we essentially engineer the indoor spaces we live in to have their own artificial immune systems?

 

CLAY

That completely redefines the boundaries of public health.

 

GENEVA

It really does. Why wait to water the one thirsty plant when you finally have the power to make it rain?